期刊文献+

Prognostic markers for idiopathic pulmonary arterial hypertension 被引量:4

Prognostic markers for idiopathic pulmonary arterial hypertension
原文传递
导出
摘要 Objective The objective of this study is to review the research on the prognostic markers of idiopathic pulmonary arterial hypertension (IPAH).Date sources We searched literature from PubMed and CNKI databases both in English and Chinese up to 2013.Study selection Data about mortality and cut-off value are from clinical trials and identified by analysis.Results IPAH is an unexplained,progressive,and rare disease characterized by increased pulmonary artery pressure and pulmonary vascular resistance.The diagnosis is difficult,mortality of IPAH is high,and the survival periods are only 2-3 years after diagnosis.Investigations in recent years have identified a range of prognostic markers for IPAH,including the 6-minute walking test,red blood cell distribution width,and platelet levels,as well as imaging findings.Changes in these markers are important sources of information to predict the prognosis of patients with IPAH,which carries significant benefits for treatment planning.Conclusion Even though the prognosis of IPAH has been investigated,the mortality is also high.More accurate and meaningful assessment for the prognosis of IPAH is required. Objective The objective of this study is to review the research on the prognostic markers of idiopathic pulmonary arterial hypertension (IPAH).Date sources We searched literature from PubMed and CNKI databases both in English and Chinese up to 2013.Study selection Data about mortality and cut-off value are from clinical trials and identified by analysis.Results IPAH is an unexplained,progressive,and rare disease characterized by increased pulmonary artery pressure and pulmonary vascular resistance.The diagnosis is difficult,mortality of IPAH is high,and the survival periods are only 2-3 years after diagnosis.Investigations in recent years have identified a range of prognostic markers for IPAH,including the 6-minute walking test,red blood cell distribution width,and platelet levels,as well as imaging findings.Changes in these markers are important sources of information to predict the prognosis of patients with IPAH,which carries significant benefits for treatment planning.Conclusion Even though the prognosis of IPAH has been investigated,the mortality is also high.More accurate and meaningful assessment for the prognosis of IPAH is required.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2014年第21期3798-3802,共5页 中华医学杂志(英文版)
基金 This work was supported by a grant from the Beijing Natural Science Foundation (No. 7121014).
关键词 pulmonary arterial hypertension PROGNOSIS prognostic markers pulmonary arterial hypertension prognosis prognostic markers
  • 相关文献

参考文献3

二级参考文献10

  • 1程显声.特发性肺动脉高压的诊断[J].中国循环杂志,2006,21(6):478-480. 被引量:8
  • 2Vaya A, Hern6ndez JL, Zorio E, et al. Association between red blood cell distribution width and the risk of future cardiovascular events. Clin Hemorheol Microcirc, 2012, 50: 221-225.
  • 3Bonaque JC, Pascual-Figal DA, Manzano-Fernandez S, et al. Red blood cell distribution width adds prognostic value for outpatients with chronic heart failure. Rev Esp Cardiol, 2012, 65:606-612.
  • 4Rhodes C J, Wharton J, Howard LS, et al. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart, 2011, 97:1054- 1060.
  • 5Hampole CV, Mehrotra AK, Thenappan T, et al. Usefulness of red cell distribution width as a prognostic marker in pulmunary hypertension. Am J Cardiol, 2009, 104: 868-872.
  • 6Rhodes C J, Wharton J, Howard L, et al. Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target. Eur Respir J, 2011, 38:1453-1460.
  • 7Ruiter G, Lankhorst S, Boonstra A, et al. Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur Respir J, 2011, 37:1386-1391.
  • 8Frhcz Z, Gomhos T, Borgulya G, et al. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart I, 2009, 158: 659-666.
  • 9JIANG Xin,HAN Zhi-yan,WANG Yong,XU Xi-qi,MA Chuan-rong,WU Yan,PAN Lei,JING Zhi-cheng.Hemodynamic variables and clinical features correlated with serum uric acid in patients with pulmonary arterial hypertension[J].Chinese Medical Journal,2008(24):2497-2503. 被引量:17
  • 10曾伟杰,孙云娟,卢献灵,熊长明,顾晴,倪新海,柳志红,程显声,何建国.5型磷酸二酯酶抑制剂改善特发性肺动脉高压患者预后[J].中国循环杂志,2011,26(2):117-120. 被引量:5

共引文献54

同被引文献8

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部